Nautilus Biotechnology, Inc. (NAUT)
2.035
0.00 (0.00%)
USD |
NASDAQ |
Dec 10, 16:00
2.035
0.00 (0.00%)
After-Hours: 20:00
Nautilus Biotechnology Total Liabilities (Quarterly): 31.78M for Sept. 30, 2025
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Prelude Therapeutics, Inc. | 36.22M |
| Protalix Biotherapeutics, Inc. | 29.36M |
| Genprex, Inc. | 2.795M |
| GoodRx Holdings, Inc. | 724.80M |
| Pelthos Therapeutics, Inc. | 68.18M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 200.92M |
| Shareholders Equity (Quarterly) | 169.14M |
| Debt to Equity Ratio | 0.1597 |
| Current Ratio | 14.95 |
| Net Debt Paydown Yield | 1.05% |